- Recent Funding
- Investors
- Samsung Securities
Samsung Securities portfolio
Samsung Securities has 6 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
It led 1 of the 5 rounds it joined. Its most recent investment on record is Fore Biotherapeutics's $67.4M Series B+ round in July 2026, alongside Windham Venture Partners, Wellington Management, Novartis Venture Fund and 6 others. By category, its portfolio leans toward Health and bio (3) and Education (2). It has co-invested with Wellington Management, OrbiMed and SR One, most often Wellington Management (2 rounds).
What Samsung Securities invests in
- Health and bio · 3 · 50%
- Education · 2 · 33%
- AI infrastructure and compute · 2 · 33%
- Robotics and hardware · 2 · 33%
- Foundation models and research · 1 · 17%
- Developer tools and cloud · 1 · 17%
- Climate and energy · 1 · 17%
Samsung Securities recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $67.4M | Windham Venture Partners, Wellington Management, Novartis Venture Fund +6 | ||
| Series B+ · $15.5M | Kiwoom Investment, SBI Investment Korea, KB Securities +6 | ||
| Series B+ · $693M · lead | Baillie Gifford, Healthcare of Ontario Pension Plan, LG Electronics +9 | ||
| Series B+ · $75M | Wellington Management, Novartis Venture Fund, SR One (lead) +5 | ||
| Series B+ · $22M | Shinhan Capital, TIGRIS investment, K2 Investment Partners +6 |
How Samsung Securities invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 5 100% | $872.9M |
Samsung Securities portfolio companies
FFore Biotherapeutics$67.4MSeries B+ · Jul 2026
DDatumo$15.5MSeries B+ · Aug 2025
TTenstorrent$693MSeries B+ · Dec 2024
PPoint2 Technology$22MSeries B+ · May 2022
IImprimedbacker
CCaredocbacker
| Company | Round with Samsung Securities | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $67.4M | $182.4M | Jul 8, 2026 Series B+ |
Foundation models and research |
Series B+ · $15.5M | $15.5M | Aug 11, 2025 Series B+ |
AI infrastructure and compute |
Series B+ · $693M · lead | $893M | Jan 7, 2026 Series B+ |
AI infrastructure and compute |
Series B+ · $22M | $234M | Jul 15, 2026 Series B+ |
Health and bio |
backer | undisclosed | Dec 19, 2023 Series A |
Health and bio |
backer | $111M | Oct 15, 2026 Series B+ |
Most frequent co-investors
WWellington Management2 shared rounds · last Jul 8, 2026
OOrbiMed2 shared rounds · last Jul 8, 2026
SSR One2 shared rounds · last Jul 8, 2026
NNovartis Venture Fund2 shared rounds · last Jul 8, 2026
MMedicxi2 shared rounds · last Jul 8, 2026
SSymBiosis1 shared round · last Jul 8, 2026
WWindham Venture Partners1 shared round · last Jul 8, 2026
- TTaiAx1 shared round · last Jul 8, 2026
PPrimer Ventures1 shared round · last Jul 8, 2026
SSalesforce Ventures1 shared round · last Aug 11, 2025
KKB Investment1 shared round · last Aug 11, 2025
KKB Securities1 shared round · last Aug 11, 2025
Similar investors
AAdage Capital Management6 companies · 4 deals in 12 mo
HHealthier Capital6 companies · 4 deals in 12 mo
UUC Investments6 companies · 4 deals in 12 moAAbingworth6 companies · 3 deals in 12 mo
HHBM Healthcare Investments6 companies · 3 deals in 12 mo
TThe FSE Group6 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 5 rounds on Recent Funding that name Samsung Securities. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Samsung Securities, which is a subset of its real portfolio. API: /api/v1/investors/samsung-securities (get a free API key). More: the most active VC firms and new venture capital funds.